IOL Chemicals and Pharmaceuticals Limited
IOLCP · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹171.62.
Piotroski F-score 5/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%7.9%
- ✓Low debt (D/E < 0.5)0.08x
- ✕Positive free cash flow
- ✓Revenue growth > 10%17%
- ✓Earnings growing70%
- ✕Net margin ≥ 10%5.9%
- ✓Current ratio > 1.51.78
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 4.72
- ✕Piotroski ≥ 75/9
1-year price
EOD · 2026-06-16Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Annual financials
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Analyst views
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 4.72.
Weaknesses
- •Low return on equity (7.9%).
Opportunities
- •Earnings growing (70% YoY).
- •Revenue growing (17% YoY).
- •Trading in our value buy zone versus sector peers.
- •Trades ~70% below our estimated fair value.
About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries
More in Healthcare
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.